Screening of primary gp120 immunogens to formulate the next generation polyvalent DNA prime-protein boost HIV-1 vaccines

Our previous preclinical studies and a Phase I clinical trial DP6-001 have indicated that a polyvalent Env formulation was able to elicit broadly reactive antibody responses including low titer neutralizing antibody responses against viral isolates of subtypes A, B, C and AE. In the current report,...

全面介绍

Saved in:
书目详细资料
Main Authors: Shixia Wang (Author), Te-hui Chou (Author), Anthony Hackett (Author), Veronica Efros (Author), Yan Wang (Author), Dong Han (Author), Aaron Wallace (Author), Yuxin Chen (Author), Guangnan Hu (Author), Shuying Liu (Author), Paul Clapham (Author), James Arthos (Author), David Montefiori (Author), Shan Lu (Author)
格式: 图书
出版: Taylor & Francis Group, 2017-12-01T00:00:00Z.
主题:
在线阅读:Connect to this object online.
标签: 添加标签
没有标签, 成为第一个标记此记录!

因特网

Connect to this object online.

3rd Floor Main Library

持有资料详情 3rd Floor Main Library
索引号: A1234.567
复印件 1 可用